Dr. Sarah Elizabeth Vollbracht, MD

Dr. Vollbracht practices at Newyork-presbyterian Medical Group/queens in Yorktown Heights, New York.

Dr. Vollbracht's NPI, 1982926325, was assigned on February 26, 2010. Dr. Vollbracht graduated from New York University Grossman School of Medicine in 2006. Dr. Vollbracht holds New York license 253452.

Dr. Vollbracht's primary practice is Newyork-presbyterian Medical Group/queens, at 2649 Strang Blvd, Yorktown Heights, NY 10598. The practice phone is (718) 670-1019.

Dr. Vollbracht's primary practice is Newyork-presbyterian Medical Group/queens in Yorktown Heights, New York. Dr. Vollbracht is also affiliated with NewYork-Presbyterian Queens. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Vollbracht to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vollbracht practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Vollbracht's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Vollbracht is licensed in New York.

Dmand AI lists head injury, lower back pain, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain and thoracic spine disorders among the conditions Dr. Vollbracht treats.

CMS data shows 27,683 Medicare services from Dr. Vollbracht across 8 procedure codes in 2024, for 168 Medicare patients. Medicare paid $191,242 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Vollbracht in 2024. The largest group is 65 to 74, with 90 patients. 68% of them have high cholesterol, and 56% have arthritis. 14% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vollbracht's median patient age at 50, with 79% women.

In 2024, Dr. Vollbracht wrote 2,839 Medicare Part D claims for 274 patients. 70% of them were for generic drugs. CMS names the drug for 2,493 of them, across 55 drugs with 11 or more claims each, at $994,599 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Vollbracht for performance year 2024, reported through an alternative payment model (APM). Dr. Vollbracht accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vollbracht as offering telehealth.

Dmand AI links 14 papers to Dr. Vollbracht, published from 2010 to 2021. 2013 was the busiest year, with 2. The most frequent topics are Migraine Disorders, Cluster Headache and Headache. Dr. Vollbracht has published most often in Headache. Dr. Vollbracht's most frequent co-authors are Matthew Stuart Robbins, MD, Cynthia Emilie Armand and Jelena Pavlovic, MD.

CMS Open Payments shows 4 general payments to Dr. Vollbracht from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $92.

Dr. Vollbracht graduated from New York University Grossman School of Medicine in 2006.

Dr. Vollbracht is in network with 17 carriers, including Aetna, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.